Fresenius Kabi, an operating company of Fresenius, announced today that the Centers for Medicare and Medicaid Services (CMS) issued a permanent, product-specific billing code for Otulfi® ...

Amgen AMGN will report first-quarter 2025 results on May 1, after market close. In the last reported quarter, the company ...

The Board of Directors of RPG Life Sciences Limited, at its meeting held today have approved the financial results of the ...

Thriving in the evolving biosimilar market demands bold collaboration, early global partnerships, and a fresh approach to development strategies to overcome uncertainty and drive future success.